 Monitoring, Immunologic
"Monitoring, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumor antigen and other markers (often by RADIOIMMUNOASSAY), studies of cellular or humoral immunity in cancer etiology, IMMUNOTHERAPY trials, etc.
| Descriptor ID |
D015166
|
| MeSH Number(s) |
E01.370.225.812.505 E01.370.520.505 E05.200.812.505 E05.478.594.550
|
| Concept/Terms |
Monitoring, Immunologic- Monitoring, Immunologic
- Immunologic Monitoring
- Monitoring, Immunological
- Immunological Monitoring
- Immune Monitoring
- Monitoring, Immune
- Immunosurveillance
Radioimmunologic Monitoring- Radioimmunologic Monitoring
- Monitoring, Radioimmunological
- Radioimmunological Monitoring
- Monitoring, Radioimmunologic
|
Below are MeSH descriptors whose meaning is more general than "Monitoring, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Monitoring, Immunologic".
This graph shows the total number of publications written about "Monitoring, Immunologic" by people in this website by year, and whether "Monitoring, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 | | 2004 | 0 | 1 | 1 | | 2009 | 1 | 0 | 1 | | 2011 | 0 | 2 | 2 | | 2012 | 0 | 1 | 1 | | 2014 | 1 | 1 | 2 | | 2018 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 | | 2023 | 0 | 1 | 1 | | 2025 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Monitoring, Immunologic" by people in Profiles.
-
Hammoudi T, Nucera S, Troullioud Lucas AG, Ansari M, Balduzzi A, Bertaina A, Buechner J, Corbacioglu S, Dalle JH, Kalwak K, Lee D, Levine JE, Lindemans CA, Locatelli F, Meisel R, Nierkens S, Ottaviano G, Perez-Martinez A, Pichler H, Prockop SE, Pulsipher MA, Talano JM, Tewari S, Schultz KR, Shah NN, Verneris MR, Boelens JJ. Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group. Blood Adv. 2025 Dec 09; 9(23):6141-6157.
-
Turner JA, Fredrickson MA, D'Antonio M, Katsnelson E, MacBeth M, Van Gulick R, Chimed TS, McCarter M, D'Alessandro A, Robinson WA, Couts KL, Pelanda R, Klarquist J, Tobin RP, Torres RM. Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity. Nat Commun. 2023 06 03; 14(1):3214.
-
Wang Y, Gloss B, Tang B, Dervish S, Santner-Nanan B, Whitehead C, Masters K, Skarratt K, Teoh S, Schibeci S, Fewings N, Brignone C, Triebel F, Booth D, McLean A, Nalos M. Immunophenotyping of Peripheral Blood Mononuclear Cells in Septic Shock Patients With High-Dimensional Flow Cytometry Analysis Reveals Two Subgroups With Differential Responses to Immunostimulant Drugs. Front Immunol. 2021; 12:634127.
-
Lynes J, Jackson S, Sanchez V, Dominah G, Wang X, Kuek A, Hayes CP, Benzo S, Scott GC, Chittiboina P, Zaghloul KA, Park DM, Wu J, Hourigan CS, Giles AJ, Wu T, Maric D, Chen J, Quezado M, Heiss JD, Gilbert MR, Nduom EK. Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade. Neurosurgery. 2019 04 01; 84(4):945-953.
-
Greenplate AR, McClanahan DD, Oberholtzer BK, Doxie DB, Roe CE, Diggins KE, Leelatian N, Rasmussen ML, Kelley MC, Gama V, Siska PJ, Rathmell JC, Ferrell PB, Johnson DB, Irish JM. Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor Types. Cancer Immunol Res. 2019 01; 7(1):86-99.
-
Paredes RM, Tadaki DK, Sooter A, Gamboni F, Sheppard F. Cryopreservation of human whole blood allows immunophenotyping by flow cytometry up to 30days after cell isolation. J Immunol Methods. 2018 01; 452:32-38.
-
Rochford R, Moormann AM. Burkitt's Lymphoma. Curr Top Microbiol Immunol. 2015; 390(Pt 1):267-85.
-
Bainbridge J, Wilkening CL, Rountree W, Louzao R, Wong J, Perza N, Garcia A, Denny TN. The Immunology Quality Assessment Proficiency Testing Program for CD3?4? and CD3?8? lymphocyte subsets: a ten year review via longitudinal mixed effects modeling. J Immunol Methods. 2014 Jul; 409:82-90.
-
Alfonso J, Gralla J, Klem P, Chan L, Wiseman AC, Cooper JE. High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported Cohorts. Clin Transpl. 2014; 161-70.
-
Lacsina JR, Marks OA, Liu X, Reid DW, Jagannathan S, Nicchitta CV. Premature translational termination products are rapidly degraded substrates for MHC class I presentation. PLoS One. 2012; 7(12):e51968.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|